

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 5.12381836 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.12381836 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.12381836 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.12381836 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.12381836 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.12381836 |
| 7 | negative regulation of cell killing (GO:0031342) | 5.11158181 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.11158181 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.97363970 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.93659131 |
| 11 | response to peptidoglycan (GO:0032494) | 4.79476734 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.76349579 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.48082431 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.38872237 |
| 15 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.35573362 |
| 16 | detection of other organism (GO:0098543) | 4.33733776 |
| 17 | negative regulation of interleukin-12 production (GO:0032695) | 4.28120650 |
| 18 | low-density lipoprotein particle clearance (GO:0034383) | 4.19374473 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.15247056 |
| 20 | detection of bacterium (GO:0016045) | 4.13330624 |
| 21 | regulation of cholesterol homeostasis (GO:2000188) | 3.96386905 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.95627612 |
| 23 | carnitine shuttle (GO:0006853) | 3.95376283 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 3.86181811 |
| 25 | fatty acid transmembrane transport (GO:1902001) | 3.85386781 |
| 26 | germinal center formation (GO:0002467) | 3.83504133 |
| 27 | detection of external biotic stimulus (GO:0098581) | 3.81558040 |
| 28 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.81168294 |
| 29 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.70140270 |
| 30 | regulation of mast cell degranulation (GO:0043304) | 3.66739657 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.64999153 |
| 32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.64154090 |
| 33 | lysine catabolic process (GO:0006554) | 3.61898158 |
| 34 | lysine metabolic process (GO:0006553) | 3.61898158 |
| 35 | cellular extravasation (GO:0045123) | 3.59612711 |
| 36 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.58411129 |
| 37 | neutrophil activation (GO:0042119) | 3.57160305 |
| 38 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.55315125 |
| 39 | granulocyte activation (GO:0036230) | 3.54715126 |
| 40 | 2-oxoglutarate metabolic process (GO:0006103) | 3.52605641 |
| 41 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.50683752 |
| 42 | immunoglobulin mediated immune response (GO:0016064) | 3.47619087 |
| 43 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.46302391 |
| 44 | response to host immune response (GO:0052572) | 3.46302391 |
| 45 | leukocyte aggregation (GO:0070486) | 3.42399519 |
| 46 | positive regulation of lipid storage (GO:0010884) | 3.41493508 |
| 47 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.39570517 |
| 48 | regulation of sequestering of triglyceride (GO:0010889) | 3.37615372 |
| 49 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.37557493 |
| 50 | response to muramyl dipeptide (GO:0032495) | 3.35432593 |
| 51 | sarcomere organization (GO:0045214) | 3.34501179 |
| 52 | detection of biotic stimulus (GO:0009595) | 3.33792430 |
| 53 | regulation of cholesterol storage (GO:0010885) | 3.32604880 |
| 54 | positive regulation of histone deacetylation (GO:0031065) | 3.30836950 |
| 55 | regulation of leukocyte degranulation (GO:0043300) | 3.30276805 |
| 56 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.29326099 |
| 57 | positive regulation of p38MAPK cascade (GO:1900745) | 3.27326286 |
| 58 | regulation of p38MAPK cascade (GO:1900744) | 3.27255231 |
| 59 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.26462285 |
| 60 | response to host (GO:0075136) | 3.26462285 |
| 61 | response to host defenses (GO:0052200) | 3.26462285 |
| 62 | positive regulation of fatty acid oxidation (GO:0046321) | 3.25896755 |
| 63 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.25872844 |
| 64 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.25700488 |
| 65 | regulation of fatty acid oxidation (GO:0046320) | 3.24052232 |
| 66 | macrophage activation (GO:0042116) | 3.20144232 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 3.17178419 |
| 68 | carnitine transmembrane transport (GO:1902603) | 3.16742731 |
| 69 | plasma membrane repair (GO:0001778) | 3.15646403 |
| 70 | valine metabolic process (GO:0006573) | 3.12496653 |
| 71 | amino-acid betaine transport (GO:0015838) | 3.10944279 |
| 72 | carnitine transport (GO:0015879) | 3.10944279 |
| 73 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.08243366 |
| 74 | alpha-linolenic acid metabolic process (GO:0036109) | 3.07388970 |
| 75 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.06826579 |
| 76 | respiratory burst (GO:0045730) | 3.06769028 |
| 77 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.06539610 |
| 78 | cellular response to type I interferon (GO:0071357) | 3.05081794 |
| 79 | type I interferon signaling pathway (GO:0060337) | 3.05081794 |
| 80 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.04873942 |
| 81 | NIK/NF-kappaB signaling (GO:0038061) | 3.04098016 |
| 82 | positive regulation of mast cell activation (GO:0033005) | 3.03149919 |
| 83 | response to type I interferon (GO:0034340) | 3.02342802 |
| 84 | negative regulation of cell size (GO:0045792) | 2.98713818 |
| 85 | 4-hydroxyproline metabolic process (GO:0019471) | 2.98103943 |
| 86 | regulation of triglyceride catabolic process (GO:0010896) | 2.95085543 |
| 87 | growth hormone receptor signaling pathway (GO:0060396) | 2.94353637 |
| 88 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.94091482 |
| 89 | positive regulation of lipid catabolic process (GO:0050996) | 2.93939031 |
| 90 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.93270848 |
| 91 | defense response to protozoan (GO:0042832) | 2.89255074 |
| 92 | plasma lipoprotein particle clearance (GO:0034381) | 2.88683498 |
| 93 | microglial cell activation (GO:0001774) | 2.88216760 |
| 94 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.88178256 |
| 95 | response to interleukin-15 (GO:0070672) | 2.87753745 |
| 96 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.87710491 |
| 97 | fatty acid beta-oxidation (GO:0006635) | 2.87395700 |
| 98 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.85241266 |
| 99 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.85128748 |
| 100 | kynurenine metabolic process (GO:0070189) | 2.82082515 |
| 101 | regulation of mast cell activation (GO:0033003) | 2.81743498 |
| 102 | tricarboxylic acid metabolic process (GO:0072350) | 2.81344615 |
| 103 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.81305222 |
| 104 | neutrophil mediated immunity (GO:0002446) | 2.80484343 |
| 105 | B cell receptor signaling pathway (GO:0050853) | 2.79002520 |
| 106 | tolerance induction (GO:0002507) | 2.78579876 |
| 107 | protein carboxylation (GO:0018214) | 2.78379385 |
| 108 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.78379385 |
| 109 | homocysteine metabolic process (GO:0050667) | 2.77612331 |
| 110 | actin-myosin filament sliding (GO:0033275) | 2.77607713 |
| 111 | muscle filament sliding (GO:0030049) | 2.77607713 |
| 112 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.76864424 |
| 113 | cysteine metabolic process (GO:0006534) | 2.76381159 |
| 114 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.75552235 |
| 115 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.75540046 |
| 116 | positive thymic T cell selection (GO:0045059) | 2.75306347 |
| 117 | cardiac myofibril assembly (GO:0055003) | 2.74595415 |
| 118 | acetyl-CoA metabolic process (GO:0006084) | 2.74211025 |
| 119 | negative regulation of T cell mediated immunity (GO:0002710) | 2.73886083 |
| 120 | regulation of T cell tolerance induction (GO:0002664) | 2.73545760 |
| 121 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.72951664 |
| 122 | response to protozoan (GO:0001562) | 2.72569201 |
| 123 | cell-substrate junction assembly (GO:0007044) | 2.71435721 |
| 124 | T-helper 1 type immune response (GO:0042088) | 2.71198149 |
| 125 | positive regulation of B cell differentiation (GO:0045579) | 2.70817556 |
| 126 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.70808359 |
| 127 | negative regulation of fibrinolysis (GO:0051918) | 2.70666558 |
| 128 | regulation of tolerance induction (GO:0002643) | 2.70626850 |
| 129 | regulation of regulated secretory pathway (GO:1903305) | 2.70393107 |
| 130 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.69644980 |
| 131 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.69438974 |
| 132 | positive regulation of mast cell degranulation (GO:0043306) | 2.69438974 |
| 133 | amino-acid betaine metabolic process (GO:0006577) | 2.68650012 |
| 134 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.67995946 |
| 135 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.66612165 |
| 136 | myeloid dendritic cell differentiation (GO:0043011) | 2.66599742 |
| 137 | negative regulation of interleukin-6 production (GO:0032715) | 2.65494105 |
| 138 | negative regulation of lipid transport (GO:0032369) | 2.65362783 |
| 139 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.64699514 |
| 140 | regulation of necroptotic process (GO:0060544) | 2.64287666 |
| 141 | modulation by symbiont of host cellular process (GO:0044068) | 2.63600287 |
| 142 | serine family amino acid catabolic process (GO:0009071) | 2.63567827 |
| 143 | desmosome organization (GO:0002934) | 2.62514112 |
| 144 | complement activation, alternative pathway (GO:0006957) | 2.62285972 |
| 145 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.61902029 |
| 146 | positive regulation of type 2 immune response (GO:0002830) | 2.60776088 |
| 147 | oxaloacetate metabolic process (GO:0006107) | 2.60614747 |
| 148 | fatty acid oxidation (GO:0019395) | 2.60614268 |
| 149 | B cell mediated immunity (GO:0019724) | 2.60152936 |
| 150 | myofibril assembly (GO:0030239) | 2.59974285 |
| 151 | creatine metabolic process (GO:0006600) | 2.59589385 |
| 152 | protein localization to endosome (GO:0036010) | 2.58611122 |
| 153 | aspartate family amino acid catabolic process (GO:0009068) | 2.58028666 |
| 154 | negative regulation of cholesterol transport (GO:0032375) | 2.57966695 |
| 155 | negative regulation of sterol transport (GO:0032372) | 2.57966695 |
| 156 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.57580646 |
| 157 | leukocyte degranulation (GO:0043299) | 2.57522152 |
| 158 | sulfur amino acid catabolic process (GO:0000098) | 2.57314743 |
| 159 | negative regulation of innate immune response (GO:0045824) | 2.57208965 |
| 160 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.56993951 |
| 161 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.56989155 |
| 162 | negative regulation of fatty acid transport (GO:2000192) | 2.55915570 |
| 163 | negative regulation of type 2 immune response (GO:0002829) | 2.55361135 |
| 164 | carnitine metabolic process (GO:0009437) | 2.55033799 |
| 165 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.54747722 |
| 166 | lipid oxidation (GO:0034440) | 2.54597353 |
| 167 | regulation of type 2 immune response (GO:0002828) | 2.53961509 |
| 168 | phospholipid homeostasis (GO:0055091) | 2.52938917 |
| 169 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.52235902 |
| 170 | cell-substrate adherens junction assembly (GO:0007045) | 2.51979587 |
| 171 | focal adhesion assembly (GO:0048041) | 2.51979587 |
| 172 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.51671077 |
| 173 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.51598909 |
| 174 | skeletal muscle adaptation (GO:0043501) | 2.50254250 |
| 175 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.49564751 |
| 176 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.49229726 |
| 177 | apoptotic cell clearance (GO:0043277) | 2.48615151 |
| 178 | urea metabolic process (GO:0019627) | 2.48506306 |
| 179 | urea cycle (GO:0000050) | 2.48506306 |
| 180 | cellular response to growth hormone stimulus (GO:0071378) | 2.45404022 |
| 181 | regulation of triglyceride metabolic process (GO:0090207) | 2.45095240 |
| 182 | epithelial cell-cell adhesion (GO:0090136) | 2.44597115 |
| 183 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.43240729 |
| 184 | negative regulation of heart growth (GO:0061117) | 2.41875840 |
| 185 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.41875840 |
| 186 | biotin metabolic process (GO:0006768) | 2.40866931 |
| 187 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.40809111 |
| 188 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.38872615 |
| 189 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.38115271 |
| 190 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.37678726 |
| 191 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.37658550 |
| 192 | apoptotic process involved in morphogenesis (GO:0060561) | 2.37248529 |
| 193 | maternal placenta development (GO:0001893) | 2.36256720 |
| 194 | quaternary ammonium group transport (GO:0015697) | 2.36180990 |
| 195 | fatty acid catabolic process (GO:0009062) | 2.35327944 |
| 196 | fatty acid homeostasis (GO:0055089) | 2.35287797 |
| 197 | positive regulation of glycogen metabolic process (GO:0070875) | 2.33718076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.31723073 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.15482308 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.86631613 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.42668299 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.34711284 |
| 6 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.31128306 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.93622957 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.89816686 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.74008936 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.52257015 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.45959391 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.38220234 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.28592624 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28232680 |
| 15 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.26006075 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.24331521 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.23122028 |
| 18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.20872735 |
| 19 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18450571 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.18126537 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.07704829 |
| 22 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.07082591 |
| 23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.06994529 |
| 24 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03520437 |
| 25 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.02789772 |
| 26 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97082034 |
| 27 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.94726809 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.93634648 |
| 29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.91151927 |
| 30 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.86539046 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.85925419 |
| 32 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85312874 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.85262986 |
| 34 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.80286535 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.78733038 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78170411 |
| 37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.77784604 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75797130 |
| 39 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.75642474 |
| 40 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.74815859 |
| 41 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.74228028 |
| 42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73524788 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72693415 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71546649 |
| 45 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70133044 |
| 46 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.68514945 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.64522393 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.61063634 |
| 49 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.61001151 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59521132 |
| 51 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.58685085 |
| 52 | * MAF_26560356_Chip-Seq_TH1_Human | 1.58102331 |
| 53 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57937141 |
| 54 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.57419555 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55842333 |
| 56 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.53704770 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.50415802 |
| 58 | MYB_26560356_Chip-Seq_TH2_Human | 1.48098095 |
| 59 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.47961326 |
| 60 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.46600392 |
| 61 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.45905434 |
| 62 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.45905434 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45445564 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.43570745 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42032745 |
| 66 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41232967 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39341589 |
| 68 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.38635621 |
| 69 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.33702072 |
| 70 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.33599852 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31518013 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31422921 |
| 73 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31047345 |
| 74 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.27529578 |
| 75 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.26727580 |
| 76 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.26300996 |
| 77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25861590 |
| 78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.25817535 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25064729 |
| 80 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.24651678 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24149451 |
| 82 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.23925617 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21843555 |
| 84 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20988220 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20946857 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20936459 |
| 87 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20601731 |
| 88 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19898108 |
| 89 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.19846302 |
| 90 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19759566 |
| 91 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17528025 |
| 92 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.17044178 |
| 93 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.16538079 |
| 94 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16433690 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15909829 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15140214 |
| 97 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.14360771 |
| 98 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13960185 |
| 99 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13834906 |
| 100 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13693170 |
| 101 | * MAF_26560356_Chip-Seq_TH2_Human | 1.10810774 |
| 102 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10501213 |
| 103 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10307633 |
| 104 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10080206 |
| 105 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.09936607 |
| 106 | P68_20966046_ChIP-Seq_HELA_Human | 1.09233290 |
| 107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07885965 |
| 108 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07300440 |
| 109 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07017668 |
| 110 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06400472 |
| 111 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06331388 |
| 112 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.06021962 |
| 113 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05384016 |
| 114 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05227741 |
| 115 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04856822 |
| 116 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.04277647 |
| 117 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.04140592 |
| 118 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03814972 |
| 119 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03701729 |
| 120 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.02621398 |
| 121 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.02348827 |
| 122 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01915420 |
| 123 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01422174 |
| 124 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00273326 |
| 125 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00267310 |
| 126 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00245186 |
| 127 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98086932 |
| 128 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98082123 |
| 129 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98006522 |
| 130 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97784913 |
| 131 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96674642 |
| 132 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96080903 |
| 133 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95738387 |
| 134 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.95669812 |
| 135 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95404751 |
| 136 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94934100 |
| 137 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94789949 |
| 138 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94091043 |
| 139 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92973215 |
| 140 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.92735495 |
| 141 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92158984 |
| 142 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91403415 |
| 143 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.90829925 |
| 144 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.89929613 |
| 145 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.89342909 |
| 146 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.88042821 |
| 147 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87709625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.96686381 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.64124250 |
| 3 | MP0003646_muscle_fatigue | 3.02618840 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.85771081 |
| 5 | MP0002419_abnormal_innate_immunity | 2.74776547 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.63311218 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.54830473 |
| 8 | MP0005025_abnormal_response_to | 2.52956681 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.52371663 |
| 10 | MP0005464_abnormal_platelet_physiology | 2.47501675 |
| 11 | MP0005360_urolithiasis | 2.46621019 |
| 12 | MP0009785_altered_susceptibility_to | 2.44681788 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.43695418 |
| 14 | MP0006082_CNS_inflammation | 2.40849505 |
| 15 | MP0009840_abnormal_foam_cell | 2.40313990 |
| 16 | MP0004185_abnormal_adipocyte_glucose | 2.39879191 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.30546010 |
| 18 | MP0001800_abnormal_humoral_immune | 2.27326855 |
| 19 | MP0003303_peritoneal_inflammation | 2.25517415 |
| 20 | MP0005671_abnormal_response_to | 2.19872895 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.19632177 |
| 22 | MP0002723_abnormal_immune_serum | 2.17485068 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.12864098 |
| 24 | MP0004510_myositis | 2.11852361 |
| 25 | MP0005666_abnormal_adipose_tissue | 2.06278924 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.06213868 |
| 27 | MP0003300_gastrointestinal_ulcer | 2.04453983 |
| 28 | MP0001819_abnormal_immune_cell | 2.03840348 |
| 29 | MP0004130_abnormal_muscle_cell | 2.03683439 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.99606769 |
| 31 | MP0005365_abnormal_bile_salt | 1.99565787 |
| 32 | MP0000750_abnormal_muscle_regeneration | 1.98876551 |
| 33 | MP0005076_abnormal_cell_differentiation | 1.97336014 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.94438654 |
| 35 | MP0004084_abnormal_cardiac_muscle | 1.94095341 |
| 36 | MP0008260_abnormal_autophagy | 1.88565614 |
| 37 | MP0005670_abnormal_white_adipose | 1.87707569 |
| 38 | MP0005085_abnormal_gallbladder_physiolo | 1.87585526 |
| 39 | MP0004087_abnormal_muscle_fiber | 1.79590686 |
| 40 | MP0008961_abnormal_basal_metabolism | 1.77835835 |
| 41 | MP0000751_myopathy | 1.75350685 |
| 42 | MP0005083_abnormal_biliary_tract | 1.72517101 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.63559527 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.63559527 |
| 45 | MP0003763_abnormal_thymus_physiology | 1.63430908 |
| 46 | MP0002398_abnormal_bone_marrow | 1.63209666 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.61509000 |
| 48 | MP0002132_abnormal_respiratory_system | 1.60537554 |
| 49 | MP0003075_altered_response_to | 1.59276314 |
| 50 | MP0004036_abnormal_muscle_relaxation | 1.57668020 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.57137774 |
| 52 | MP0005375_adipose_tissue_phenotype | 1.55806145 |
| 53 | MP0000716_abnormal_immune_system | 1.55522447 |
| 54 | MP0005330_cardiomyopathy | 1.55257739 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.54075897 |
| 56 | MP0009764_decreased_sensitivity_to | 1.52920330 |
| 57 | MP0003252_abnormal_bile_duct | 1.48554461 |
| 58 | MP0010630_abnormal_cardiac_muscle | 1.47953853 |
| 59 | MP0003436_decreased_susceptibility_to | 1.45571979 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.45340423 |
| 61 | MP0010329_abnormal_lipoprotein_level | 1.44201590 |
| 62 | MP0000609_abnormal_liver_physiology | 1.42334777 |
| 63 | MP0000749_muscle_degeneration | 1.40476234 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.40116061 |
| 65 | MP0008469_abnormal_protein_level | 1.38810648 |
| 66 | MP0008004_abnormal_stomach_pH | 1.38116397 |
| 67 | MP0002796_impaired_skin_barrier | 1.37372456 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 1.34832602 |
| 69 | MP0009278_abnormal_bone_marrow | 1.33777209 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 1.32303767 |
| 71 | MP0002106_abnormal_muscle_physiology | 1.31889728 |
| 72 | MP0002722_abnormal_immune_system | 1.30687416 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 1.30091181 |
| 74 | MP0002429_abnormal_blood_cell | 1.29567429 |
| 75 | MP0000689_abnormal_spleen_morphology | 1.29209841 |
| 76 | MP0002269_muscular_atrophy | 1.28877302 |
| 77 | MP0005451_abnormal_body_composition | 1.27976525 |
| 78 | MP0005310_abnormal_salivary_gland | 1.27856992 |
| 79 | MP0000733_abnormal_muscle_development | 1.24382529 |
| 80 | MP0004947_skin_inflammation | 1.23531587 |
| 81 | MP0000759_abnormal_skeletal_muscle | 1.23171084 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 1.21626767 |
| 83 | MP0003828_pulmonary_edema | 1.21154603 |
| 84 | MP0005023_abnormal_wound_healing | 1.20235399 |
| 85 | MP0002254_reproductive_system_inflammat | 1.17420238 |
| 86 | MP0005385_cardiovascular_system_phenoty | 1.13890693 |
| 87 | MP0001544_abnormal_cardiovascular_syste | 1.13890693 |
| 88 | MP0002971_abnormal_brown_adipose | 1.13716374 |
| 89 | MP0001851_eye_inflammation | 1.11326310 |
| 90 | MP0003866_abnormal_defecation | 1.09970874 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 1.09260396 |
| 92 | MP0000703_abnormal_thymus_morphology | 1.08442304 |
| 93 | MP0005166_decreased_susceptibility_to | 1.07486786 |
| 94 | MP0008875_abnormal_xenobiotic_pharmacok | 1.07243384 |
| 95 | MP0000604_amyloidosis | 1.06164402 |
| 96 | MP0003690_abnormal_glial_cell | 1.05930080 |
| 97 | MP0008775_abnormal_heart_ventricle | 1.05835749 |
| 98 | MP0000747_muscle_weakness | 1.04052889 |
| 99 | MP0005275_abnormal_skin_tensile | 1.03945358 |
| 100 | MP0001853_heart_inflammation | 1.03876260 |
| 101 | MP0000343_altered_response_to | 1.02433499 |
| 102 | MP0002118_abnormal_lipid_homeostasis | 1.01961385 |
| 103 | MP0010234_abnormal_vibrissa_follicle | 1.00361793 |
| 104 | MP0005620_abnormal_muscle_contractility | 0.99831047 |
| 105 | MP0002972_abnormal_cardiac_muscle | 0.97133429 |
| 106 | MP0005369_muscle_phenotype | 0.96947810 |
| 107 | MP0003183_abnormal_peptide_metabolism | 0.96339485 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.95865614 |
| 109 | MP0005164_abnormal_response_to | 0.95724168 |
| 110 | MP0002877_abnormal_melanocyte_morpholog | 0.94733747 |
| 111 | MP0004808_abnormal_hematopoietic_stem | 0.94556466 |
| 112 | MP0000003_abnormal_adipose_tissue | 0.93978199 |
| 113 | MP0004883_abnormal_blood_vessel | 0.93427178 |
| 114 | MP0004381_abnormal_hair_follicle | 0.93413193 |
| 115 | MP0005167_abnormal_blood-brain_barrier | 0.93111263 |
| 116 | MP0005332_abnormal_amino_acid | 0.92913629 |
| 117 | MP0004858_abnormal_nervous_system | 0.90849219 |
| 118 | MP0001663_abnormal_digestive_system | 0.90148425 |
| 119 | MP0010368_abnormal_lymphatic_system | 0.90028321 |
| 120 | MP0001666_abnormal_nutrient_absorption | 0.88949387 |
| 121 | MP0002396_abnormal_hematopoietic_system | 0.88914914 |
| 122 | MP0009643_abnormal_urine_homeostasis | 0.88009376 |
| 123 | MP0009763_increased_sensitivity_to | 0.87010974 |
| 124 | MP0004215_abnormal_myocardial_fiber | 0.86264354 |
| 125 | MP0002060_abnormal_skin_morphology | 0.85527097 |
| 126 | MP0005501_abnormal_skin_physiology | 0.84609855 |
| 127 | MP0000767_abnormal_smooth_muscle | 0.84523044 |
| 128 | MP0005390_skeleton_phenotype | 0.83691630 |
| 129 | MP0006138_congestive_heart_failure | 0.83393404 |
| 130 | MP0004145_abnormal_muscle_electrophysio | 0.82643561 |
| 131 | MP0000685_abnormal_immune_system | 0.82166110 |
| 132 | MP0001849_ear_inflammation | 0.82095367 |
| 133 | MP0002277_abnormal_respiratory_mucosa | 0.81868611 |
| 134 | MP0009053_abnormal_anal_canal | 0.80019175 |
| 135 | MP0001873_stomach_inflammation | 0.79580427 |
| 136 | MP0001216_abnormal_epidermal_layer | 0.78175839 |
| 137 | MP0009115_abnormal_fat_cell | 0.77853146 |
| 138 | MP0000598_abnormal_liver_morphology | 0.77835245 |
| 139 | MP0003045_fibrosis | 0.76312518 |
| 140 | MP0000266_abnormal_heart_morphology | 0.76120915 |
| 141 | MP0003448_altered_tumor_morphology | 0.75518151 |
| 142 | MP0008874_decreased_physiological_sensi | 0.75300315 |
| 143 | MP0000249_abnormal_blood_vessel | 0.74629178 |
| 144 | MP0005334_abnormal_fat_pad | 0.73788229 |
| 145 | MP0000490_abnormal_crypts_of | 0.72589814 |
| 146 | MP0008438_abnormal_cutaneous_collagen | 0.72224638 |
| 147 | MP0010155_abnormal_intestine_physiology | 0.71197341 |
| 148 | MP0005387_immune_system_phenotype | 0.70554380 |
| 149 | MP0001790_abnormal_immune_system | 0.70554380 |
| 150 | MP0001533_abnormal_skeleton_physiology | 0.70053630 |
| 151 | MP0003795_abnormal_bone_structure | 0.69032543 |
| 152 | MP0003091_abnormal_cell_migration | 0.68490719 |
| 153 | MP0009931_abnormal_skin_appearance | 0.67683148 |
| 154 | MP0003656_abnormal_erythrocyte_physiolo | 0.67282060 |
| 155 | MP0002405_respiratory_system_inflammati | 0.66630766 |
| 156 | MP0004484_altered_response_of | 0.66052709 |
| 157 | MP0002088_abnormal_embryonic_growth/wei | 0.64872541 |
| 158 | MP0000858_altered_metastatic_potential | 0.64869448 |
| 159 | MP0003329_amyloid_beta_deposits | 0.64843161 |
| 160 | MP0009765_abnormal_xenobiotic_induced | 0.64178707 |
| 161 | MP0003941_abnormal_skin_development | 0.63952618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 4.95362177 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.74499268 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.63831815 |
| 4 | Myositis (HP:0100614) | 4.49576870 |
| 5 | Orchitis (HP:0100796) | 4.44892193 |
| 6 | Increased connective tissue (HP:0009025) | 4.04901817 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.03892412 |
| 8 | Optic neuritis (HP:0100653) | 4.03892412 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.99582254 |
| 10 | Muscle fiber splitting (HP:0003555) | 3.90590059 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 3.82048605 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 3.81475148 |
| 13 | Exercise-induced myalgia (HP:0003738) | 3.80985680 |
| 14 | Ventricular tachycardia (HP:0004756) | 3.67960931 |
| 15 | Stomatitis (HP:0010280) | 3.64665962 |
| 16 | Exercise-induced muscle cramps (HP:0003710) | 3.63935222 |
| 17 | Myoglobinuria (HP:0002913) | 3.62468526 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.58699427 |
| 19 | Obstructive lung disease (HP:0006536) | 3.58699427 |
| 20 | Difficulty running (HP:0009046) | 3.57123941 |
| 21 | Sudden death (HP:0001699) | 3.56010923 |
| 22 | Prolonged bleeding time (HP:0003010) | 3.54165820 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.49412033 |
| 24 | Increased IgE level (HP:0003212) | 3.44735486 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.37713339 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.37392279 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.29459891 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.29459891 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.29459891 |
| 30 | Deep venous thrombosis (HP:0002625) | 3.24329718 |
| 31 | Difficulty climbing stairs (HP:0003551) | 3.19674290 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.16766231 |
| 33 | Purpura (HP:0000979) | 3.14708420 |
| 34 | Keratoconjunctivitis sicca (HP:0001097) | 3.04873005 |
| 35 | Xanthomatosis (HP:0000991) | 3.03216513 |
| 36 | Polycythemia (HP:0001901) | 3.02326725 |
| 37 | Rhabdomyolysis (HP:0003201) | 3.02283699 |
| 38 | Meningitis (HP:0001287) | 3.00899922 |
| 39 | Petechiae (HP:0000967) | 3.00491399 |
| 40 | Asymmetric septal hypertrophy (HP:0001670) | 2.95758062 |
| 41 | Myocardial infarction (HP:0001658) | 2.94866942 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.93470800 |
| 43 | Cellulitis (HP:0100658) | 2.92933067 |
| 44 | Recurrent fungal infections (HP:0002841) | 2.91989417 |
| 45 | Gingivitis (HP:0000230) | 2.90498174 |
| 46 | Epistaxis (HP:0000421) | 2.87697041 |
| 47 | Vasculitis (HP:0002633) | 2.82973245 |
| 48 | Recurrent skin infections (HP:0001581) | 2.80948609 |
| 49 | Urticaria (HP:0001025) | 2.75358232 |
| 50 | Keratoconjunctivitis (HP:0001096) | 2.70098485 |
| 51 | Encephalitis (HP:0002383) | 2.68703722 |
| 52 | Calf muscle hypertrophy (HP:0008981) | 2.67986730 |
| 53 | Gingival bleeding (HP:0000225) | 2.67019394 |
| 54 | Loss of speech (HP:0002371) | 2.66956035 |
| 55 | Hypoalphalipoproteinemia (HP:0003233) | 2.66382629 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.63864735 |
| 57 | Type 1 muscle fiber predominance (HP:0003803) | 2.63846842 |
| 58 | Hyperglycinuria (HP:0003108) | 2.63395451 |
| 59 | Amyloidosis (HP:0011034) | 2.61130037 |
| 60 | Muscle fiber inclusion bodies (HP:0100299) | 2.56397950 |
| 61 | Chest pain (HP:0100749) | 2.53296551 |
| 62 | Episodic fever (HP:0001954) | 2.51726627 |
| 63 | Arterial thrombosis (HP:0004420) | 2.50490019 |
| 64 | Hypoglycemic coma (HP:0001325) | 2.49857080 |
| 65 | Increased serum ferritin (HP:0003281) | 2.49273159 |
| 66 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.48828581 |
| 67 | Abnormality of the Achilles tendon (HP:0005109) | 2.47911550 |
| 68 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.46980653 |
| 69 | Ketosis (HP:0001946) | 2.44808349 |
| 70 | Myopathic facies (HP:0002058) | 2.41726041 |
| 71 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.40241300 |
| 72 | Abnormal platelet volume (HP:0011876) | 2.37779059 |
| 73 | EMG: myopathic abnormalities (HP:0003458) | 2.37245597 |
| 74 | Esophageal varix (HP:0002040) | 2.36965158 |
| 75 | Hypochromic anemia (HP:0001931) | 2.36180150 |
| 76 | Pulmonary infiltrates (HP:0002113) | 2.35712165 |
| 77 | Bundle branch block (HP:0011710) | 2.35356703 |
| 78 | Achilles tendon contracture (HP:0001771) | 2.34947409 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.34218573 |
| 80 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.34171620 |
| 81 | Subaortic stenosis (HP:0001682) | 2.34171620 |
| 82 | Gastrointestinal inflammation (HP:0004386) | 2.30648906 |
| 83 | Hypochromic microcytic anemia (HP:0004840) | 2.30643686 |
| 84 | Complement deficiency (HP:0004431) | 2.30146379 |
| 85 | Atrioventricular block (HP:0001678) | 2.29527982 |
| 86 | Ketoacidosis (HP:0001993) | 2.29389663 |
| 87 | Inflammation of the large intestine (HP:0002037) | 2.28396653 |
| 88 | Hyperammonemia (HP:0001987) | 2.26957319 |
| 89 | Recurrent viral infections (HP:0004429) | 2.26246588 |
| 90 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.23515836 |
| 91 | Abnormality of the calf musculature (HP:0001430) | 2.22966594 |
| 92 | Increased IgM level (HP:0003496) | 2.22197551 |
| 93 | Cerebral aneurysm (HP:0004944) | 2.20301313 |
| 94 | Pulmonary embolism (HP:0002204) | 2.19581274 |
| 95 | Hemoptysis (HP:0002105) | 2.18979474 |
| 96 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.18934229 |
| 97 | Lipoatrophy (HP:0100578) | 2.18136648 |
| 98 | Gout (HP:0001997) | 2.15363019 |
| 99 | Pustule (HP:0200039) | 2.14692639 |
| 100 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.14495619 |
| 101 | Abnormal atrioventricular conduction (HP:0005150) | 2.14373705 |
| 102 | Abnormality of glycine metabolism (HP:0010895) | 2.14323187 |
| 103 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.14323187 |
| 104 | Hepatosplenomegaly (HP:0001433) | 2.13991600 |
| 105 | Abnormality of iron homeostasis (HP:0011031) | 2.13732743 |
| 106 | Frequent falls (HP:0002359) | 2.13531986 |
| 107 | Distal lower limb muscle weakness (HP:0009053) | 2.13149271 |
| 108 | Disinhibition (HP:0000734) | 2.13084345 |
| 109 | Intrahepatic cholestasis (HP:0001406) | 2.12172541 |
| 110 | Colitis (HP:0002583) | 2.12065356 |
| 111 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.11942174 |
| 112 | Ulnar deviation of the wrist (HP:0003049) | 2.10240581 |
| 113 | Vacuolated lymphocytes (HP:0001922) | 2.10214405 |
| 114 | Round ear (HP:0100830) | 2.10117649 |
| 115 | Osteomyelitis (HP:0002754) | 2.07113486 |
| 116 | Anorexia (HP:0002039) | 2.06661715 |
| 117 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.06084088 |
| 118 | Recurrent cutaneous fungal infections (HP:0011370) | 2.06084088 |
| 119 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.05972705 |
| 120 | Abnormality of complement system (HP:0005339) | 2.05644074 |
| 121 | Aneurysm (HP:0002617) | 2.05526054 |
| 122 | Heart block (HP:0012722) | 2.05418607 |
| 123 | Autoimmune thrombocytopenia (HP:0001973) | 2.05172477 |
| 124 | Microcytic anemia (HP:0001935) | 2.03596591 |
| 125 | Gangrene (HP:0100758) | 2.02928762 |
| 126 | Leukocytosis (HP:0001974) | 2.02827992 |
| 127 | Hypertensive crisis (HP:0100735) | 2.01177636 |
| 128 | Slow saccadic eye movements (HP:0000514) | 2.01158532 |
| 129 | Menorrhagia (HP:0000132) | 2.00469621 |
| 130 | Hypolipoproteinemia (HP:0010981) | 2.00000457 |
| 131 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.99677532 |
| 132 | Gastrointestinal stroma tumor (HP:0100723) | 1.98640304 |
| 133 | Nasal polyposis (HP:0100582) | 1.98638871 |
| 134 | Interstitial pulmonary disease (HP:0006530) | 1.97992862 |
| 135 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.97792364 |
| 136 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.97792364 |
| 137 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.97792364 |
| 138 | Increased density of long bones (HP:0006392) | 1.97199785 |
| 139 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.96235036 |
| 140 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.96066787 |
| 141 | Hypergammaglobulinemia (HP:0010702) | 1.95446341 |
| 142 | Acne (HP:0001061) | 1.95304254 |
| 143 | Reticulocytosis (HP:0001923) | 1.95061243 |
| 144 | Abnormality of purine metabolism (HP:0004352) | 1.94361837 |
| 145 | Lymphangioma (HP:0100764) | 1.93922108 |
| 146 | Broad metatarsal (HP:0001783) | 1.93902746 |
| 147 | Systemic lupus erythematosus (HP:0002725) | 1.93557175 |
| 148 | Impaired platelet aggregation (HP:0003540) | 1.91497083 |
| 149 | Abnormal platelet function (HP:0011869) | 1.91497083 |
| 150 | Muscle stiffness (HP:0003552) | 1.91482675 |
| 151 | Areflexia of lower limbs (HP:0002522) | 1.91219214 |
| 152 | Abnormality of the peritoneum (HP:0002585) | 1.91101854 |
| 153 | Mitral valve prolapse (HP:0001634) | 1.90930360 |
| 154 | Hyperglycemia (HP:0003074) | 1.89405313 |
| 155 | Protrusio acetabuli (HP:0003179) | 1.89333524 |
| 156 | Limb-girdle muscle atrophy (HP:0003797) | 1.89209923 |
| 157 | Abnormality of the nasal mucosa (HP:0000433) | 1.89181834 |
| 158 | Hydroxyprolinuria (HP:0003080) | 1.88941730 |
| 159 | Abnormality of proline metabolism (HP:0010907) | 1.88941730 |
| 160 | EMG: neuropathic changes (HP:0003445) | 1.88859227 |
| 161 | Neonatal death (HP:0003811) | 1.88462861 |
| 162 | Cholelithiasis (HP:0001081) | 1.88243915 |
| 163 | Late onset (HP:0003584) | 1.88050962 |
| 164 | Hyperglycinemia (HP:0002154) | 1.86659812 |
| 165 | Increased variability in muscle fiber diameter (HP:0003557) | 1.85719582 |
| 166 | Distal lower limb amyotrophy (HP:0008944) | 1.84914702 |
| 167 | Sepsis (HP:0100806) | 1.84795806 |
| 168 | Skin nodule (HP:0200036) | 1.83374869 |
| 169 | Axonal loss (HP:0003447) | 1.83007699 |
| 170 | Hemorrhage of the eye (HP:0011885) | 1.82983851 |
| 171 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.82910460 |
| 172 | Upper limb amyotrophy (HP:0009129) | 1.82806692 |
| 173 | Distal upper limb amyotrophy (HP:0007149) | 1.82806692 |
| 174 | Glomerulopathy (HP:0100820) | 1.82640660 |
| 175 | Mucopolysacchariduria (HP:0008155) | 1.82580053 |
| 176 | Hyperlipoproteinemia (HP:0010980) | 1.81700667 |
| 177 | Shallow orbits (HP:0000586) | 1.81092320 |
| 178 | Eczematoid dermatitis (HP:0000976) | 1.79116823 |
| 179 | Rectal prolapse (HP:0002035) | 1.78785991 |
| 180 | Acanthosis nigricans (HP:0000956) | 1.77945667 |
| 181 | Multiple enchondromatosis (HP:0005701) | 1.77168844 |
| 182 | Facial diplegia (HP:0001349) | 1.75927365 |
| 183 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.74472704 |
| 184 | Ventricular arrhythmia (HP:0004308) | 1.74396745 |
| 185 | Nemaline bodies (HP:0003798) | 1.73966847 |
| 186 | Epidermoid cyst (HP:0200040) | 1.73956344 |
| 187 | Dilated cardiomyopathy (HP:0001644) | 1.73034409 |
| 188 | Peritonitis (HP:0002586) | 1.71533493 |
| 189 | Abnormal cartilage morphology (HP:0002763) | 1.71074600 |
| 190 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.70361377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.12497115 |
| 2 | RIPK4 | 4.06636936 |
| 3 | ERN1 | 3.50385126 |
| 4 | TTN | 3.30334170 |
| 5 | PKN2 | 3.04662380 |
| 6 | PRPF4B | 2.89219568 |
| 7 | MAP3K10 | 2.70699165 |
| 8 | IRAK4 | 2.60388224 |
| 9 | BLK | 2.37295720 |
| 10 | EEF2K | 2.04459157 |
| 11 | FGFR4 | 2.02071424 |
| 12 | SIK1 | 1.99798886 |
| 13 | CDK12 | 1.98276427 |
| 14 | EPHB1 | 1.88677354 |
| 15 | RIPK1 | 1.86646624 |
| 16 | PTK6 | 1.86549160 |
| 17 | MAP3K3 | 1.83775269 |
| 18 | MAP2K3 | 1.81121951 |
| 19 | BCKDK | 1.80003676 |
| 20 | LATS1 | 1.79559338 |
| 21 | MAP4K1 | 1.71660965 |
| 22 | DMPK | 1.67897217 |
| 23 | FES | 1.57615077 |
| 24 | TAOK1 | 1.55345955 |
| 25 | TNK2 | 1.52478561 |
| 26 | TBK1 | 1.52424305 |
| 27 | FGR | 1.51834177 |
| 28 | SIK3 | 1.41237829 |
| 29 | MAP3K13 | 1.41038085 |
| 30 | MAP3K11 | 1.39541210 |
| 31 | SMG1 | 1.38679392 |
| 32 | BTK | 1.33044272 |
| 33 | NEK1 | 1.31608579 |
| 34 | TYK2 | 1.29882091 |
| 35 | MAP3K7 | 1.25097985 |
| 36 | PDK4 | 1.23049110 |
| 37 | PDK3 | 1.23049110 |
| 38 | ICK | 1.22593411 |
| 39 | MARK2 | 1.21840031 |
| 40 | STK10 | 1.21094037 |
| 41 | SYK | 1.18570355 |
| 42 | BMX | 1.17914446 |
| 43 | PHKG1 | 1.15386253 |
| 44 | PHKG2 | 1.15386253 |
| 45 | MATK | 1.15330699 |
| 46 | OBSCN | 1.15266512 |
| 47 | TGFBR2 | 1.13175720 |
| 48 | CAMK1D | 1.12523925 |
| 49 | MTOR | 1.10721242 |
| 50 | EPHA3 | 1.10275111 |
| 51 | LRRK2 | 1.09209764 |
| 52 | RPS6KA4 | 1.05469451 |
| 53 | IRAK2 | 1.04593839 |
| 54 | CDC42BPA | 0.98143754 |
| 55 | SIK2 | 0.97828198 |
| 56 | JAK1 | 0.95420432 |
| 57 | LYN | 0.95095741 |
| 58 | IRAK1 | 0.92883481 |
| 59 | PDGFRA | 0.91951432 |
| 60 | MAPKAPK3 | 0.91173132 |
| 61 | STK38L | 0.88308454 |
| 62 | PRKD2 | 0.88109396 |
| 63 | TXK | 0.87166162 |
| 64 | CDK4 | 0.86637803 |
| 65 | CSF1R | 0.85889757 |
| 66 | ALK | 0.84732433 |
| 67 | STK3 | 0.83342516 |
| 68 | CHUK | 0.82699413 |
| 69 | CDK6 | 0.82126389 |
| 70 | PRKAA2 | 0.81705369 |
| 71 | CSK | 0.81156521 |
| 72 | JAK2 | 0.80918164 |
| 73 | LATS2 | 0.78978931 |
| 74 | FGFR3 | 0.78676295 |
| 75 | JAK3 | 0.78535173 |
| 76 | HIPK2 | 0.78279441 |
| 77 | PDK1 | 0.78165198 |
| 78 | EPHA2 | 0.77910457 |
| 79 | TESK2 | 0.76157649 |
| 80 | GRK6 | 0.75736268 |
| 81 | ZAP70 | 0.75721118 |
| 82 | LCK | 0.75497142 |
| 83 | PIK3CG | 0.72502904 |
| 84 | MAP3K5 | 0.71734709 |
| 85 | CAMK1G | 0.70940366 |
| 86 | PTK2 | 0.68594074 |
| 87 | MAP3K2 | 0.68382946 |
| 88 | YES1 | 0.68346274 |
| 89 | PRKAA1 | 0.68315658 |
| 90 | NEK9 | 0.68184296 |
| 91 | EPHB2 | 0.66419575 |
| 92 | DYRK1B | 0.66003051 |
| 93 | MAPK11 | 0.64397246 |
| 94 | MAP3K1 | 0.63540037 |
| 95 | BMPR2 | 0.62950945 |
| 96 | NME2 | 0.62936111 |
| 97 | PDK2 | 0.62892937 |
| 98 | NEK2 | 0.62871007 |
| 99 | KDR | 0.62053859 |
| 100 | IKBKE | 0.61500629 |
| 101 | SGK3 | 0.60991215 |
| 102 | MAP3K6 | 0.60957799 |
| 103 | MOS | 0.60728734 |
| 104 | IRAK3 | 0.60499247 |
| 105 | STK24 | 0.60294890 |
| 106 | PAK4 | 0.57753921 |
| 107 | TAOK3 | 0.57625223 |
| 108 | PRKD3 | 0.57435970 |
| 109 | MAP3K8 | 0.56411015 |
| 110 | IKBKB | 0.56376521 |
| 111 | RPS6KA1 | 0.55649504 |
| 112 | PIM1 | 0.55497267 |
| 113 | MST1R | 0.55182880 |
| 114 | MAP2K2 | 0.54443761 |
| 115 | GSK3A | 0.52761612 |
| 116 | LMTK2 | 0.52685293 |
| 117 | PRKD1 | 0.51540962 |
| 118 | ILK | 0.50216582 |
| 119 | GRK7 | 0.49781225 |
| 120 | ITK | 0.49319646 |
| 121 | RET | 0.48581661 |
| 122 | FLT3 | 0.48203202 |
| 123 | STK38 | 0.48122692 |
| 124 | TAOK2 | 0.47669099 |
| 125 | KSR1 | 0.46466635 |
| 126 | RPS6KA2 | 0.45913617 |
| 127 | MAP3K14 | 0.45788170 |
| 128 | MAPK12 | 0.43409434 |
| 129 | RPS6KA6 | 0.42955103 |
| 130 | FYN | 0.42683463 |
| 131 | DDR2 | 0.41371056 |
| 132 | MARK3 | 0.40993763 |
| 133 | HCK | 0.40726469 |
| 134 | RPS6KL1 | 0.40038218 |
| 135 | RPS6KC1 | 0.40038218 |
| 136 | PDGFRB | 0.39592535 |
| 137 | KIT | 0.39006797 |
| 138 | MAPK7 | 0.38919704 |
| 139 | KSR2 | 0.38144616 |
| 140 | MAPKAPK2 | 0.37936815 |
| 141 | RAF1 | 0.37797894 |
| 142 | PDPK1 | 0.37685555 |
| 143 | CDK9 | 0.37326675 |
| 144 | RPS6KB2 | 0.37276615 |
| 145 | MAPK4 | 0.35837961 |
| 146 | MAP2K6 | 0.35393874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.58516206 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.59290530 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43956110 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.24092416 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.15757111 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.12289959 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.07887804 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.03320987 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.00263854 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 1.97432910 |
| 11 | Malaria_Homo sapiens_hsa05144 | 1.90861778 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90343672 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.89149112 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.84717937 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.82593998 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77933060 |
| 17 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.77545616 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77359746 |
| 19 | Insulin resistance_Homo sapiens_hsa04931 | 1.76171395 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.70140297 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.69094456 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68090596 |
| 23 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.67088468 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.65392742 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.65065255 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62241653 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.50409848 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.49649780 |
| 29 | Lysine degradation_Homo sapiens_hsa00310 | 1.47909014 |
| 30 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.47334733 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45305621 |
| 32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.42153846 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37628482 |
| 34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.37117590 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.35376146 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30686674 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.29352707 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.26856916 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.26675696 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.22938581 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.22112857 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21386456 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.21262397 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20736895 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.17930570 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17486629 |
| 47 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.14216113 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 1.13723513 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.13509975 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12607666 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 1.12441355 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.10964039 |
| 53 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.10618772 |
| 54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09573883 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08158521 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 1.06984738 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.06075358 |
| 58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.03533112 |
| 59 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.03140361 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03122736 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02590222 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02352220 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01998930 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.01309229 |
| 65 | Leishmaniasis_Homo sapiens_hsa05140 | 0.99615893 |
| 66 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.99543945 |
| 67 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99500423 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 0.99484253 |
| 69 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95558372 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94538076 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94223517 |
| 72 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.93577905 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.93314835 |
| 74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92887329 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.91160917 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.89444849 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.87750548 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86498991 |
| 79 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.86447796 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.86400026 |
| 81 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86324145 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84050543 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.84008176 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83881090 |
| 85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83805179 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83145876 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82527683 |
| 88 | Asthma_Homo sapiens_hsa05310 | 0.82322768 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.82109550 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82055723 |
| 91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.81991383 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.81964037 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79112527 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78469999 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.77902915 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.77852840 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77532253 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.77453280 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77245177 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77011154 |
| 101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75794739 |
| 102 | Legionellosis_Homo sapiens_hsa05134 | 0.72606896 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.72403994 |
| 104 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71872101 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71756110 |
| 106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70933780 |
| 107 | ABC transporters_Homo sapiens_hsa02010 | 0.70340851 |
| 108 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70022611 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68958302 |
| 110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68760925 |
| 111 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68289244 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68025795 |
| 113 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67704336 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67586575 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67016624 |
| 116 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64825507 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64690434 |
| 118 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64428094 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63398877 |
| 120 | Apoptosis_Homo sapiens_hsa04210 | 0.63005855 |
| 121 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.60582080 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60148576 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59696636 |
| 124 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59127239 |
| 125 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.58538185 |
| 126 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58270124 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57592791 |
| 128 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55992868 |
| 129 | Influenza A_Homo sapiens_hsa05164 | 0.55663386 |
| 130 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54475432 |
| 131 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53450559 |
| 132 | Prostate cancer_Homo sapiens_hsa05215 | 0.53325653 |
| 133 | Glioma_Homo sapiens_hsa05214 | 0.53230337 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53218112 |
| 135 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52822934 |
| 136 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52638586 |
| 137 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51864958 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51348074 |
| 139 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50074069 |
| 140 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49865624 |
| 141 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49320374 |
| 142 | Galactose metabolism_Homo sapiens_hsa00052 | 0.49312069 |
| 143 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49240314 |
| 144 | Hepatitis C_Homo sapiens_hsa05160 | 0.47069579 |
| 145 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45858961 |
| 146 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.45356727 |
| 147 | Measles_Homo sapiens_hsa05162 | 0.44770991 |
| 148 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44249989 |
| 149 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43714697 |
| 150 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43234627 |
| 151 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42876269 |
| 152 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42605073 |
| 153 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42405762 |
| 154 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42275177 |
| 155 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41912533 |
| 156 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40719818 |
| 157 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40468101 |

